C-type lectin receptor dectin-3 mediates trehalose 6,6'-dimycolate (TDM)-induced Mincle expression through CARD9/Bcl10/MALT1-dependent nuclear factor (NF)-κB activation

J Biol Chem. 2014 Oct 24;289(43):30052-62. doi: 10.1074/jbc.M114.588574. Epub 2014 Sep 8.

Abstract

Previous studies indicate that both Dectin-3 (also called MCL or Clec4d) and Mincle (also called Clec4e), two C-type lectin receptors, can recognize trehalose 6,6'-dimycolate (TDM), a cell wall component from mycobacteria, and induce potent innate immune responses. Interestingly, stimulation of Dectin-3 by TDM can also induce Mincle expression, which may enhance the host innate immune system to sense Mycobacterium infection. However, the mechanism by which Dectin-3 induces Mincle expression is not fully defined. Here, we show that TDM-induced Mincle expression is dependent on Dectin-3-mediated NF-κB, but not nuclear factor of activated T-cells (NFAT), activation, and Dectin-3 induces NF-κB activation through the CARD9-BCL10-MALT1 complex. We found that bone marrow-derived macrophages from Dectin-3-deficient mice were severely defective in the induction of Mincle expression in response to TDM stimulation. This defect is correlated with the failure of TDM-induced NF-κB activation in Dectin-3-deficient bone marrow-derived macrophages. Consistently, inhibition of NF-κB, but not NFAT, impaired TDM-induced Mincle expression, whereas NF-κB, but not NFAT, binds to the Mincle promoter. Dectin-3-mediated NF-κB activation is dependent on the CARD9-Bcl10-MALT1 complex. Finally, mice deficient for Dectin-3 or CARD9 produced much less proinflammatory cytokines and keyhole limpet hemocyanin (KLH)-specific antibodies after immunization with an adjuvant containing TDM. Overall, this study provides the mechanism by which Dectin-3 induces Mincle expression in response to Mycobacterium infection, which will have significant impact to improve adjuvant and design vaccine for antimicrobial infection.

Keywords: Innate Immunity; Lectin; NF-kappa B (NF-κB); NF-κB Transcription Factor; Signal Transduction.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adaptor Proteins, Signal Transducing / deficiency
  • Adaptor Proteins, Signal Transducing / metabolism*
  • Adjuvants, Immunologic / pharmacology
  • Animals
  • B-Cell CLL-Lymphoma 10 Protein
  • CARD Signaling Adaptor Proteins / deficiency
  • CARD Signaling Adaptor Proteins / metabolism*
  • Caspases / deficiency
  • Caspases / metabolism*
  • Cord Factors / pharmacology*
  • Cytokines / biosynthesis
  • Gene Expression Regulation / drug effects
  • Humans
  • Lectins, C-Type / deficiency
  • Lectins, C-Type / genetics*
  • Lectins, C-Type / metabolism*
  • Membrane Proteins / genetics*
  • Membrane Proteins / metabolism
  • Mice, Inbred C57BL
  • Models, Biological
  • Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein
  • NF-kappa B / metabolism*
  • NFATC Transcription Factors / metabolism
  • Neoplasm Proteins / deficiency
  • Neoplasm Proteins / metabolism*
  • Promoter Regions, Genetic / genetics
  • Protein Multimerization / drug effects
  • Protein Subunits / metabolism
  • Receptors, Immunologic / deficiency
  • Receptors, Immunologic / metabolism*
  • Signal Transduction / drug effects
  • Transcription Factor RelA / metabolism

Substances

  • Adaptor Proteins, Signal Transducing
  • Adjuvants, Immunologic
  • B-Cell CLL-Lymphoma 10 Protein
  • Bcl10 protein, mouse
  • CARD Signaling Adaptor Proteins
  • Card9 protein, mouse
  • Clec4d protein, mouse
  • Clecsf8 protein, mouse
  • Cord Factors
  • Cytokines
  • Lectins, C-Type
  • Membrane Proteins
  • NF-kappa B
  • NFATC Transcription Factors
  • Neoplasm Proteins
  • Protein Subunits
  • Receptors, Immunologic
  • Transcription Factor RelA
  • Caspases
  • Malt1 protein, mouse
  • Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein